SEOUL - Amid the South Korean biopharmaceutical industry's recent increasing focus on open innovation, more companies in the country are now adopting diverse strategies to strengthen and expand their R&D activities.
Hanmi Pharmaceutical Group is emerging at the forefront of this rush and is taking an active role in creating open...


![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)



